Effect of an Intensive Weight-Loss Lifestyle Intervention on Kidney Function: A Randomized Controlled Trial
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Introduction: Large randomized trials testing the effect of a multifactorial weight-loss lifestyle intervention including Mediterranean diet (MedDiet) on renal function are lacking. Here, we evaluated the 1-year efficacy of an intensive weight-loss intervention with an energy-reduced MedDiet (erMedDiet) plus increased physical activity (PA) on renal function. Methods: Randomized controlled “PREvención con DIeta MEDiterránea-Plus” (PREDIMED-Plus) trial is conducted in 23 Spanish centers comprising 208 primary care clinics. Overweight/obese (n = 6,719) adults aged 55–75 years with metabolic syndrome were randomly assigned (1:1) to an intensive weight-loss lifestyle intervention with an erMedDiet, PA promotion, and behavioral support (intervention) or usual-care advice to adhere to an energy-unrestricted MedDiet (control) between September 2013 and December 2016. The primary outcome was 1-year change in estimated glomerular filtration rate (eGFR). Secondary outcomes were changes in urine albumin-to-creatinine ratio (UACR), incidence of moderately/severely impaired eGFR (<60 mL/min/1.73 m2) and micro- to macroalbuminuria (UACR ≥30 mg/g), and reversion of moderately (45 to <60 mL/min/1.73 m2) to mildly impaired GFR (60 to <90 mL/min/1.73 m2) or micro- to macroalbuminuria. Results: After 1 year, eGFR declined by 0.66 and 1.25 mL/min/1.73 m2 in the intervention and control groups, respectively (mean difference, 0.58 mL/min/1.73 m2; 95% CI: 0.15–1.02). There were no between-group differences in mean UACR or micro- to macroalbuminuria changes. Moderately/severely impaired eGFR incidence and reversion of moderately to mildly impaired GFR were 40% lower (HR 0.60; 0.44–0.82) and 92% higher (HR 1.92; 1.35–2.73), respectively, in the intervention group. Conclusions: The PREDIMED-Plus lifestyle intervention approach may preserve renal function and delay CKD progression in overweight/obese adults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1800389 · Cited by 3,616
Self-citationChronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
Gansevoort, R. T., Correa-Rotter, R., Hemmelgarn, B. R., Jafar, T. H., Heerspink, H. J. L., Mann, J. F., Matsushita, K., & Wen, C. P. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60595-4 · Cited by 2,213 · cited 2×
“It should be noted that our population was comprised of older individuals with overweight/obesity and MetS, which are well-known risk factors for accelerated eGFR decline over and above that imposed by natural ageing.(2,3) Our ndings reinforce the importance of weight loss through a healthy lifestyle on preserving ren…”
BackgroundEsposito, K., Marfella, R., Ciotola, M., Di Palo, C., Giugliano, F., Giugliano, G., D'Armiento, M., D'Andrea, F., & Giugliano, D. (2004) · JAMA · doi:10.1001/jama.292.12.1440 · Cited by 2,126
Effects of a Mediterranean-Style Diet on Cardiovascular Risk Factors: A Randomized Trial
Estruch, R., Martínez-González, M. Á., Corella, D., Salas-Salvadó, J., Ruiz-Gutiérrez, V., Covas, M. I., Fiol, M., Gómez-Gracia, E., López-Sabater, M. C., Vinyoles, E., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-1-200607040-00004 · Cited by 1,704
Self-citationSchröder, H., Fitó, M., Estruch, R., Martínez-González, M. A., Corella, D., Salas-Salvadó, J., Lamuela-Raventós, R., Ros, E., Salaverría, I., Fiol, M., et al. (2011) · The Journal of Nutrition · doi:10.3945/jn.110.135566 · Cited by 1,624
Self-citationFernández-Ballart, J. D., Piñol, J. L., Zazpe, I., Corella, D., Carrasco, P., Toledo, E., Perez-Bauer, M., Martínez-González, M. Á., Salas-Salvadó, J., & Martín-Moreno, J. M. (2010) · British Journal of Nutrition · doi:10.1017/s0007114509993837 · Cited by 898
Self-citationPrevention of Diabetes With Mediterranean Diets: A Subgroup Analysis of a Randomized Trial
Salas-Salvadó, J., Bulló, M., Estruch, R., Ros, E., Covas, M.-I., Ibarrola-Jurado, N., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1725 · Cited by 650 · cited 1×
“Additionally, in prior PREDIMED reports we showed that an ad libitum MedDiet protects against kidney dysfunction-related comorbidities, such as hypertension (33), diabetes (34), and MetS (35).”
MethodSelf-citation(2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70156-1 · Cited by 319
Toledo, E., Hu, F. B., Estruch, R., Buil-Cosiales, P., Corella, D., Salas-Salvadó, J., Covas, M. I., Arós, F., Gómez-Gracia, E., Fiol, M., et al. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-207 · Cited by 289 · cited 1×
“Additionally, in prior PREDIMED reports we showed that an ad libitum MedDiet protects against kidney dysfunction-related comorbidities, such as hypertension (33), diabetes (34), and MetS (35).”
MethodSelf-citationDíaz-López, A., Babio, N., Martínez-González, M. A., Corella, D., Amor, A. J., Fitó, M., Estruch, R., Arós, F., Gómez-Gracia, E., Fiol, M., et al. (2015) · Diabetes Care · doi:10.2337/dc15-1117 · Cited by 147
Self-citation
Cited by
Obesity and chronic kidney disease
Jiang, Z., Wang, Y., Zhao, X., Cui, H., Han, M., Ren, X., Gang, X., & Wang, G. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00179.2022 · Cited by 267
Ndumele, C. E., Rodriguez, F., Dixon, D. L., Khan, S. S., Mukherjee, D., Bajaj, M., Bangalore, S., Bozkurt, B., Breathett, K., Clarke, S. L., et al. (2026) · JACC · doi:10.1016/j.jacc.2026.03.056 · Cited by 90
Treating chronic diseases without tackling excess adiposity promotes multimorbidity
Sattar, N., McMurray, J. J. V., McInnes, I. B., Aroda, V. R., & Lean, M. E. J. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00317-5 · Cited by 69
Metadata
- Authors
- Díaz-López, A., Becerra-Tomás, N., Ruiz, V., Toledo, E., Babio, N., Corella, D., Fitó, M., Romaguera, D., Vioque, J., Alonso-Gómez, Á. M., Wärnberg, J., Martínez, J. A., Serra-Majem, L., Estruch, R., Tinahones, F. J., Lapetra, J., Pintó, X., Tur, J. A., López-Miranda, J., Cano Ibañez, N., Delgado-Rodríguez, M., Matía-Martín, P., Daimiel, L., de Paz, J. A., Vidal, J., Vázquez, C., Ruiz-Canela, M., Bulló, M., Sorlí, J. V., Goday, A., Fiol, M., García-de-la-Hera, M., Tojal Sierra, L., Pérez-Farinós, N., Zulet, M. Á., Sánchez-Villegas, A., Sacanella, E., Fernández-García, J. C., Santos-Lozano, J. M., Gimenez-Gracia, M., del Mar Bibiloni, M., Diez-Espino, J., Ortega-Azorin, C., Castañer, O., Morey, M., Torres-Collado, L., Sorto Sanchez, C., Muñoz, M. Á., Ros, E., Martinez-Gonzalez, M. A., Salas-Salvadó, J., & the PREDIMED-Plus Investigators
- Venue
- American Journal of Nephrology
- Publisher
- S. Karger AG
- Published
- 2021
- Volume
- 52
- Issue
- 1
- Pages
- 45-58
- ISSN
- 0250-8095 (ISSN-L)
- 1421-9670
- OpenAlex
- W3109392941
- Cited by
- 46
- References
- 12
- FWCI
- 4.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of an Intensive Weight-Loss Lifestyle Intervention on Kidney Function: A Randomized Controlled Trial. https://app.cochat.ai/papers/10.1159/000513664
- The paper
- Díaz-López, A., Becerra-Tomás, N., Ruiz, V., Toledo, E., Babio, N., Corella, D., Fitó, M., Romaguera, D., Vioque, J., Alonso-Gómez, Á. M., Wärnberg, J., Martínez, J. A., Serra-Majem, L., Estruch, R., Tinahones, F. J., Lapetra, J., Pintó, X., Tur, J. A., López-Miranda, J., . . . the PREDIMED-Plus Investigators. (2021). Effect of an Intensive Weight-Loss Lifestyle Intervention on Kidney Function: A Randomized Controlled Trial. American Journal of Nephrology. https://doi.org/10.1159/000513664
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.